Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03